Health Catalyst Capital is a private equity and venture capital firm that specializes in growth-stage investments within the U.S. healthcare information technology and tech-enabled services sectors. The firm focuses on scaling digital health platforms, AI-driven diagnostics, and value-based care models to enhance care quality, access, and affordability.
80% of their portfolio is in Healthcare. Deal activity decreased year-over-year (1 deals in the last 12 months vs 3 prior). Their most common stage is series-b (40% of deals). Average disclosed round size is $38.9M (across 12 rounds with reported amounts).
Portfolio
15
Fund Size
—
Top Stage
Series B
Last 12 Mo
1
Team
Charles Boorady
Founding Managing Director/Managing Partner
Darshana Zaveri
Partner
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 AtaCor Medical, Inc. | Growth | $75M | Oct 2025 |
 Esperto Medical | Series A | — | Feb 2025 |
| BBrixton Biosciences | Series B | $33M | May 2024 |
 Avive Solutions, Inc. | Growth | $56.5M | Apr 2024 |
 Vivante Health | Series B | $31M | Sep 2023 |
 Rejoni, Inc. | Series B | $25M | Dec 2022 |
 Pager | Series C | $70M | Sep 2021 |
 Insightin Health | Series A | $12M | Feb 2021 |
 Conformal Medical, Inc. | Series C | $85M | Aug 2020 |
| Conformal Medical, Inc. | Series B | $9M | Dec 2018 |
 ReferWell | Growth | — | Nov 2016 |
| MMaxwell Health | Series B | $26.4M | Dec 2014 |
| Pager | Series B | $22M | — |
 Simplifeye | Unknown | — | — |
| HHolmusk | Series A | $21.5M | — |
Top Co-Investors
Last updated: 13 March 2026